Jefferies analyst Gena Wang is looking through the Oncothyreon (NASDAQ: ONTY) Phase 1b data to a more comprehensive update ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE